PLAU and neoplasm: One way of achieving this was based on the prerequisite of proteolytic activation of PA on the cell surface along with the understanding that tumor cells produces higher level of urokinase-type plasminogen activator (uPA) and cell-surface matrix metalloproteinases (MMPs) (Figure 7).